Modified Cell Expansion and Uses Thereof
AssigneeInnovative Cellular Therapeutics, Inc.
InventorsLei Xiao, Zhiyuan Cao, Chengfei Pu, He Sun
Life of this patent
Estimating the term…
Loading patent…
AssigneeInnovative Cellular Therapeutics, Inc.
InventorsLei Xiao, Zhiyuan Cao, Chengfei Pu, He Sun
Estimating the term…
The present disclosure relates to compositions and methods for enhancing T cell response and/or CAR cell expansion and/or maintenance in vivo and/or in vitro. For example, a method of enhancing T cell-based therapy comprises administering genetically modified T cells comprising a first chimeric antigen receptor (CAR) and a second CAR, wherein a binding domain of the first CAR binds a first antigen, and a binding domain of the second CAR binds a second antigen. The first antigen is different from the second antigen. In embodiments, the first CAR binds a surface molecule or antigen of a white blood cell.
A method of enhancing expansion of cells in a subject or treating the subject having cancer, the method comprising:
Dependencies are inferred from the claim text.